Search

for
Search:

GlossaryCutaneous Lupus Erythematosus Disease Area and Severity Index

tool to measure skin severity in cutaneous lupus erythematosus

The Cutaneous Lupus Erythematosus Disease Area and Severity Index (CLASI) is a tool used by healthcare professionals to assess the severity and extent of skin involvement in patients with cutaneous lupus erythematosus. It quantifies both the activity (such as redness and scaling) and damage (like scarring and pigment changes) of the disease, helping to guide treatment decisions and monitor disease progression.

Related Terms

Research

5 / 1000+ results

research Validation of the Cutaneous Lupus Disease Area and Severity Index (CLASI) using physician- and patient-assessed health outcome measures

40 citations , October 2012 in “Journal of the American Academy of Dermatology”

CLASI is a valid tool for assessing skin activity and damage in lupus patients.

research Outcome Measures in Cutaneous Autoimmune Disease: Dermatomyositis and Lupus Erythematosus

2 citations , January 2006 in “Technical report”

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

research Overview of common, rare and atypical manifestations of cutaneous lupus erythematosus and histopathological correlates

157 citations , August 2010 in “Lupus”

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.